Pharmaceuticals News and Research

RSS

Proteus receives U.S. patent for ingestible digital devices

Proteus Biomedical Inc., a pioneer in intelligent medicine, announced today that the United States Patent Office awarded U.S. Patent Number 7,978,064 to Proteus.

14 Jul 2011

Humira's early-line growth threatens Enbrel's future uptake in psoriatic arthritis

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that while Amgen/Pfizer's Enbrel was the most widely used tumor necrosis factor (TNF)-alpha inhibitor for recently treated psoriatic arthritis patients in the fourth quarter of 2010, Abbott's Humira has superseded Enbrel as an early-line TNF-alpha inhibitor for newly diagnosed psoriatic arthritis patients. Humira's early-line growth threatens Enbrel's future uptake in psoriatic arthritis.

14 Jul 2011

Scientists discover new mechanism of drug resistance in hospital microbes

Hospitals struggle to prevent the infections that complicate treatment for cancer, joint replacement, heart surgery and other conditions. Hospital-acquired infections are often resistant to multiple antibiotics, leading to approximately 100,000 deaths and more than $30 billion in additional health care costs yearly.

14 Jul 2011

Five-year research initiative to cure HIV disease

A team of AIDS experts at Johns Hopkins and other institutions have embarked on a joint five-year research initiative to cure HIV disease by finding ways to completely purge the virus from the body in people already successfully suppressing the virus with antiretroviral drug therapy.

14 Jul 2011

Accelrys releases Discovery Studio software for biotherapeutics research

Accelrys, Inc., a leading scientific enterprise R&D software and services company, today announced a new release of the Discovery Studio life sciences modeling and simulation software.

14 Jul 2011

SAS expands Global Certification Program offerings

SAS, the leader in business analytics software and services and the de facto industry standard for clinical data analysis and reporting in the life sciences/pharmaceutical industry, today expanded its Global Certification Program offerings with the introduction of a new credential - SAS Certified Clinical Trials Programmer using SAS9.

14 Jul 2011

Teva acquires Taiyo

Teva Pharmaceutical Industries Ltd. announced today that it has completed the acquisition of effectively 100% of the outstanding shares of Taiyo Pharmaceutical Industry Co. Ltd. for $934 million in cash.

14 Jul 2011

Eisai's DACOGEN sNDA for acute myeloid leukemia accepted by FDA for review

SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that Eisai Inc. today released information that the U.S. Food and Drug Administration (FDA) has accepted for review its supplemental New Drug Application (sNDA) seeking approval of DACOGEN (decitabine) for injection in the treatment of acute myeloid leukemia.

14 Jul 2011

ASLAN, Array sign license agreement to develop ARRY-543 for solid tumors

ASLAN Pharmaceuticals Pte Ltd and Array BioPharma Inc. today announced a license agreement to develop Array's HER2 / EGFR inhibitor, ARRY-543, currently entering Phase 2 development for solid tumors.

14 Jul 2011

Adamis receives European patent for novel cell-based cancer vaccine technology

Adamis Pharmaceuticals Corporation, today announced the technology which constitutes the basis of a novel cell-based cancer vaccine, TeloB-VAX, was recently granted a patent in Europe.

14 Jul 2011

Viewpoints: Prominent Republicans against IPAB; docs defend health law; medical marijuana research

The IPAB has created "immediate uncertainty at hand," says Scott & White Healthcare in central Texas, for their 12 hospitals and more than 800 physicians. Many more organizations and associations have expressed similar concerns and urged me to do what I can to repeal this ill-conceived bureaucratic board. That's why I have introduced the Health Care Bureaucrats Elimination Act, and why I'm testifying Wednesday on the other side of the Capitol to build support in the House.

14 Jul 2011

Kinexus introduces new KiNET-Antibody Microarray website

Kinexus Bioinformatics Corporation, a world-leader in molecular intelligence research, announced a major expansion in its KiNET DataBank for the study of cell communication systems with the launch of the KiNET-Antibody Microarray website.

13 Jul 2011

JSPH, Worldwide Clinical Trials partner to meet demands of healthcare reform

Worldwide Clinical Trials Inc., a leading, global provider of clinical research services, and Thomas Jefferson University's School of Population Health (JSPH), under the direction of David B. Nash, MD, MBA, today announced that they have entered into an alliance to provide pharmaceutical and biotechnology clients with a broad range of outcomes research services including comparative effectiveness, burden of illness, and quality of life studies.

13 Jul 2011

Gilead becomes first company to license drugs to Medicines Patent Pool

"In the first agreement between a pharmaceutical company and the new international Medicines Patent Pool, Gilead Sciences announced Tuesday that it would license four of its AIDS and hepatitis B drugs to the pool," the New York Times reports.

13 Jul 2011

Gerresheimer second quarter revenues increase 5.9% to EUR 284.5m

Gerresheimer AG, one of the leading global suppliers to the pharma and healthcare industry, has closed successfully the second quarter of the 2011 financial year

13 Jul 2011

U.S. hospitals report severe drug shortages: Survey

A survey called “Impact of Drug Shortages on U.S. Health Systems” released this Tuesday showed that a vast majority of U.S. hospitals have restricted the use of life-saving chemotherapy drugs and other critical-care medications in the past six months to cope with unprecedented shortages.

13 Jul 2011

Positive results from sarilumab Phase 2b trial on RA, ankylosing spondylitis

Sanofi and Regeneron Pharmaceuticals, Inc. announced results from Phase 2b trials in rheumatoid arthritis (RA) and ankylosing spondylitis (AS) with sarilumab, a novel, high-affinity, subcutaneously administered, fully-human antibody targeting the interleukin-6 receptor.

13 Jul 2011

Arena reports APD811 Phase 1 trial results against pulmonary arterial hypertension

Arena Pharmaceuticals, Inc. announced today results from a Phase 1 clinical trial of APD811, an orally bioavailable agonist of the prostacyclin receptor which is intended for the treatment of pulmonary arterial hypertension, or PAH.

13 Jul 2011

Thermo Fisher Scientific streamlines microplate tracking

Thermo Fisher Scientific Inc., the world leader in serving science, today announced its new Thermo Scientific Nunc barcode configurator, an online tool that provides an easy, convenient way to design and order custom barcoded Nunc plates online. With the ability to specify the number of digits, code type, prefixes or suffixes and label location via a simple step-by-step user interface at www.thermoscientific.com/barcodeconfigurator, visitors to the site can build a barcoding label scheme to best suit their application needs.

From Thermo Fisher Scientific Inc. 12 Jul 2011